Cipla Ltd.

Cipla’s wholly owned subsidiary -- Cipla (EU) has entered into a joint venture agreement with Kemwell Biopharma UK and MNI Ventures, Mauritius on January 5, 2024 for incorporation of a joint venture (JV) company in USA. The JV entity is being incorporated with an objective of commercialising novel cell therapy products in USA, Japan and EU region.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.